NCT03688074 Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) Status COMPLETED Phase PHASE2
NCT03656666 The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus Status UNKNOWN Phase PHASE2
NCT03638128 Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis Imperfecta Status TERMINATED Phase PHASE3
NCT03636373 Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout Status TERMINATED Phase PHASE4
NCT03635957 Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout Status COMPLETED Phase PHASE4
NCT03635021 Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03633708 A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis Status RECRUITING Phase PHASE3
NCT03626662 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a) Status COMPLETED Phase PHASE1
NCT03619993 Patient Preference for Pegfilgrastim (Neulasta®) Application Forms Status COMPLETED Phase NA
NCT03619187 An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients Status WITHDRAWN Phase PHASE3
NCT03608657 Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE) Status COMPLETED Phase N/A
NCT03600883 A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03597009 A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion Status TERMINATED Phase PHASE1/PHASE2
NCT03584711 FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation Status COMPLETED Phase PHASE2
NCT03571828 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma Status TERMINATED Phase PHASE1